The implications of pharmacogenomics in oncology

Jean J. Latimer

doi:10.34172/bi.2023.27686

The implications of pharmacogenomics in oncology

Jean J. Latimer

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	181-182
Number of pages	2
Journal	BioImpacts
Volume	13
Issue number	3
DOIs	https://doi.org/10.34172/bi.2023.27686
State	Published - May 1 2023

ASJC Scopus Subject Areas

General Biochemistry,Genetics and Molecular Biology
Pharmaceutical Science

Disciplines

Pharmacy and Pharmaceutical Sciences
Biochemistry, Biophysics, and Structural Biology

Access to Document

10.34172/bi.2023.27686

Cite this

@article{ae47636b7b1b43f7b200eed23ae9e329,

title = "The implications of pharmacogenomics in oncology",

author = "Latimer, \{Jean J.\}",

year = "2023",

month = may,

day = "1",

doi = "10.34172/bi.2023.27686",

language = "English",

volume = "13",

pages = "181--182",

journal = "BioImpacts",

issn = "2228-5652",

publisher = "Tabriz University of Medical Sciences",

number = "3",

}

TY - JOUR

T1 - The implications of pharmacogenomics in oncology

AU - Latimer, Jean J.

PY - 2023/5/1

Y1 - 2023/5/1

UR - https://www.scopus.com/pages/publications/85165704984

UR - https://www.scopus.com/pages/publications/85165704984#tab=citedBy

U2 - 10.34172/bi.2023.27686

DO - 10.34172/bi.2023.27686

M3 - Article

C2 - 37431482

AN - SCOPUS:85165704984

SN - 2228-5652

VL - 13

SP - 181

EP - 182

JO - BioImpacts

JF - BioImpacts

IS - 3

ER -

The implications of pharmacogenomics in oncology

ASJC Scopus Subject Areas

Disciplines

Access to Document

Other files and links

Cite this